| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |